Medtronic, Nvidia collaborate to build AI platform for medical devices

Nvidia (NVDA) announced that it is collaborating with Medtronic (MDT) "to accelerate the development of AI in the healthcare system and bring new AI-based solutions into patient care." The companies will integrate Nvidia healthcare and edge AI technologies into Medtronic’s GI Genius intelligent endoscopy module, developed and manufactured by Cosmo Pharmaceuticals. GI Genius is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer. GI Genius has been designed to host a suite of AI algorithms and integrating the Nvidia Clara healthcare platform could allow Medtronic to scale development of algorithms for real-time procedures, potentially accelerating AI innovation for better patient care. Medtronic intends to integrate Nvidia Holoscan – a real-time AI computing software platform for building medical devices – and Nvidia IGX, an industrial-grade edge AI hardware platform, to run with its GI Genius AI-assisted colonoscopy system to support physicians with AI-enhanced diagnostic images. Holoscan helps bring the latest AI applications into clinical settings by providing the full-stack infrastructure needed for scalable, software-defined processing of streaming data at the edge. The Nvidia Holoscan and IGX platform makes software-defined medical devices possible by enabling developers to efficiently train and validate AI models within the Cosmo Innovation Center, and then host the AI-powered applications on Medtronic’s GI Genius AI Access Platform, a marketplace for software-as-a-medical-device applications. The first GI Genius systems built with the Nvidia technology will be available later this year.